Bacterial Histidine Kinase and the Development of Its Inhibitors in the 21st Century

Author:

Ahsan Ragib1,Kifayat Sumaiya1,Pooniya Krishan Kumar1,Kularia Sunita2,Adimalla Bhavani Sailu3,Sanapalli Bharat Kumar Reddy4ORCID,Sanapalli Vidyasrilekha5ORCID,Sigalapalli Dilep Kumar6ORCID

Affiliation:

1. Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University, Jaipur 303121, Rajasthan, India

2. Department of Pharmacology, NIMS Institute of Pharmacy, NIMS University, Jaipur 303121, Rajasthan, India

3. Department of Pharmaceutical Analysis, Vignan Pharmacy College, Jawaharlal Nehru Technological University, Vadlamudi, Guntur 522213, Andhra Pradesh, India

4. Department of Pharmacology, School of Pharmacy & Technology Management, SVKM’s Narsee Monjee Institute of Management Studies (NMIMS) Deemed to-be-University, Jadcherla 509301, Hyderabad, India

5. Department of Pharmaceutical Chemistry, School of Pharmacy & Technology Management, SVKM’s Narsee Monjee Institute of Management Studies (NMIMS) Deemed to-be-University, Jadcherla 509301, Hyderabad, India

6. Department of Biochemistry, University of Washington, Seattle, WA 98195, USA

Abstract

Bacterial histidine kinase (BHK) is a constituent of the two-component signaling (TCS) pathway, which is responsible for the regulation of a number of processes connected to bacterial pathogenicity, virulence, biofilm development, antibiotic resistance, and bacterial persistence. As BHK regulation is diverse, inhibitors can be developed, such as antibiotic synergists, bacteriostatic/bactericidal agents, virulence inhibitors, and biofilm inhibitors. Inhibition of essential BHK has always been an amenable strategy due to the conserved binding sites of the domains across bacterial species and growth dependence. Hence, an inhibitor of BHK might block multiple TCS regulatory networks. This review describes the TCS system and the role of BHK in bacterial virulence and discusses the available inhibitors of BHK, which is a specific response regulator with essential structural features.

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3